OLINK HOLDING AB (PUBL) AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement March 29, 2021Deposit Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments • New York
DEPOSIT AGREEMENT dated as of March 29, 2021 among OLINK HOLDING AB (PUBL), a public limited company incorporated under the laws of Sweden (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.
OEM SUPPLY & DEVELOPMENT AGREEMENTDevelopment Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments • California
This Agreement is made and entered into by and between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjölds väg 52B, SE-752 37 Uppsala, Sweden (hereinafter referred to as “Olink”), and Fluidigm Corporation, a Delaware corporation organized and existing under the laws of the United States of America, with its principal office at Two Tower Place, Suite 2000, South San Francisco, CA 94080 USA (hereinafter referred to as “Fluidigm”).
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED PURSUANT TO THE INSTRUCTIONS TO FORM 20-F AND SEC RULES AND REGULATIONS. SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Development Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments
Amendment No. 2 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Fluidigm Corporation, a Delaware corporation organized and existing under the laws of the United States of America, with its principal office at Two Tower Place, Suite 2000, South San Francisco, CA 94080 USA ("Fluidigm"), and together with Olink, the "Parties", and each, a "Party".
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED PURSUANT TO THE INSTRUCTIONS TO FORM 20-F AND SEC RULES AND REGULATIONS. SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Development Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments
Amendment No. 1 to OEM Supply & Development Agreement (the “Amendment”), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden (“Olink”), and Fluidigm Corporation, a Delaware corporation organized and existing under the laws of the United States of America, with its principal office at Two Tower Place, Suite 2000, South San Francisco, CA 94080 USA (“Fluidigm”), and together with Olink, the “Parties”, and each, a “Party”.
REGISTRATION RIGHTS AGREEMENTAccession Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 25 March, 2021 by and among Olink Holding AB (publ), Reg. No. 559189-7755, a limited liability company incorporated under the laws of Sweden, or any of its assignees or successors (the “Company”), Knilo InvestCo AB, Reg. No. 559189-7748 , or any of its assignees or successors (the “Summa Investor”), each of the shareholders listed on Schedule A hereto (each an “Existing Shareholder”, collectively, the “Existing Shareholders” and, together with the Summa Investor(s), the “Existing Investors”), and any Person that becomes a party hereto pursuant to Section 2.15.
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED PURSUANT TO THE INSTRUCTIONS TO FORM 20-F AND SEC RULES AND REGULATIONS. SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR...Development Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments
Amendment No. 3 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Fluidigm Corporation, a Delaware corporation organized and existing under the laws of the United States of America, with its principal office at Two Tower Place, Suite 2000, South San Francisco, CA 94080 USA ("Fluidigm"), and together with Olink, the "Parties", and each, a "Party".
SHAREHOLDER AGREEMENT datedShareholder Agreement • March 17th, 2022 • Olink Holding AB (Publ) • Laboratory analytical instruments
